Green Thumb Industries (GTBIF) Capital Expenditures (2019 - 2026)
Green Thumb Industries (GTBIF) reported Capital Expenditures of $18.9 million for Q1 2026, down 36.81% on a YoY basis from $29.8 million in Q1 2025, and up 28.45% quarter-over-quarter from $14.7 million in Q4 2025.
Green Thumb Industries (GTBIF) Capital Expenditures (2019 - 2026) Analysis & Trends
Green Thumb Industries has reported Capital Expenditures for 8 years, with the latest figure at $18.9 million in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 36.81% year-over-year to $18.9 million; the trailing twelve-month figure through Mar 2026 stood at $70.1 million (down 26.47% YoY), and the FY2025 full-year result was $81.1 million, up 1.1% from the prior year.
- Capital Expenditures for Q1 2026 stood at $18.9 million, up from $14.7 million in the prior quarter.
- The five-year high for Capital Expenditures was $65.0 million in Q1 2023, with the low at $14.3 million in Q2 2022.
- Historically, Capital Expenditures has averaged $34.1 million across 5 years, with a median of $27.2 million in 2024.
- Annual changes were most pronounced in 2023 — Capital Expenditures jumped 350.23% — and 2024, when it sank 77.37%.
- Green Thumb Industries' Capital Expenditures stood at $59.6 million in 2022, then sank by 38.89% to $36.4 million in 2023, then retreated by 25.37% to $27.2 million in 2024, then slumped by 46.02% to $14.7 million in 2025, then increased by 28.45% to $18.9 million in 2026.
- The last three Capital Expenditures figures came in at $18.9 million (Q1 2026), $14.7 million (Q4 2025), and $17.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 2.04 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 8.83 Mn |
| 10 | Green Thumb Industries | - | - | 143.65 Mn | 18.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.86 Mn |
| Mar 31, 2026 | 18.86 Mn |
| Dec 31, 2025 | 14.68 Mn |
| Dec 31, 2025 | 14.68 Mn |
| Sep 30, 2025 | 17.55 Mn |
| Sep 30, 2025 | 17.55 Mn |
| Jun 30, 2025 | 19.00 Mn |
| Jun 30, 2025 | 19.00 Mn |
| Mar 31, 2025 | 29.84 Mn |
| Mar 31, 2025 | 29.84 Mn |
| Dec 31, 2024 | 27.20 Mn |
| Dec 31, 2024 | 27.20 Mn |
| Sep 30, 2024 | 18.03 Mn |
| Sep 30, 2024 | 18.03 Mn |
| Jun 30, 2024 | 20.25 Mn |
| Jun 30, 2024 | 20.25 Mn |
| Mar 31, 2024 | 14.71 Mn |
| Mar 31, 2024 | 14.71 Mn |
| Dec 31, 2023 | 36.44 Mn |
| Dec 31, 2023 | 36.44 Mn |